1-3 of 3
Satoshi Yoshihara, MD, PhD
Close
Sort by
Journal Articles

Minimal Residual Disease Assessment Using Euroflow-NGF in Patients with Multiple Myeloma Treated with a Combination of Carfilzomib, Lenalidomide, and Dexamethasone (KRD)

Takeshi Yoroidaka, MD, Hiroyuki Takamatsu, MD PhD, Takeshi Yamashita, MD, Ryoichi Murata, MD, Kyoko Yoshihara, MD PhD, Satoshi Yoshihara, MD PhD, Mikio Ueda, MD PhD, Shinji Nakao, MD PhD, Kosei Matsue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3130.
https://doi.org/10.1182/blood-2019-126552
Published: 2019
Journal Articles

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Shinichi Ishii, MD, Kazuhiro Ikegame, MD, PhD, Katsuji Kaida, MD, Satoshi Yoshihara, MD, PhD, Masaya Okada, MD, PhD, Ruri Kato, MD, Takayuki Inoue, MD, Hiroya Tamaki, MD, PhD, Yoshihiro Fujimori, MD, PhD, Toshihiro Soma, Hiroyasu Ogawa, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4203.
https://doi.org/10.1182/blood.V120.21.4203.4203
Published: 2012
Journal Articles

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Katsuji Kaida, MD, Kazuhiro Ikegame, MD, PhD, Satoshi Yoshihara, MD, PhD, Kyoko Taniguchi, MD, Shinichi Ishii, MD, Ruri Kato, MD, Takayuki Inoue, MD, Masaya Okada, MD, PhD, Hiroya Tamaki, MD, PhD, Tatsuya Fujioka, MD, PhD, Toshihiro Soma, MD, PhD, Hiroyasu Ogawa, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4117.
https://doi.org/10.1182/blood.V118.21.4117.4117
Published: 2011